TITLE

PRIMARY CUTANEOUS ASPERGILLOSIS DIX TO ASPERGILLUS NIGER IN AN IMMUNOCOMPETENT PATIENT

AUTHOR(S)
Mohapatra, S.; Xess, I.; Swetha, J. V.; Tanveer, N.; Asati, D.; Ramam, M.; Singh, M. K.
PUB. DATE
October 2009
SOURCE
Indian Journal of Medical Microbiology;Oct2009, Vol. 27 Issue 4, p367
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Primary cutaneous aspergillosis is a rare entity, usually caused by A. fumigatus and A. flavus. Here, we present such a case, manifested by ulceration due to A. niger, which remained undiagnosed for a prolonged period. The immunological status was intact, although the patient had associated severe fungal infection. Recurrence of the lesion occurred despite repeated anti-fungal therapies. Anti fungal testing was done based on the broth dilution (M-38A, NCCLS, USA) method. The culture isolate was found to be sensitive to fluconazole and amphotericin B. Continuation of antifungal therapy improved the symptoms, reducing the size of the lesion.
ACCESSION #
44320262

 

Related Articles

  • Amphotericin B liposomal.  // Reactions Weekly;1/26/2008, Issue 1186, p8 

    The article describes the case of four patients who developed hyperphosphataemia during treatment with amphotericin B liposomal for invasive mycoses. An 11-year-old boy, who had Aspergillosis fumigatis, received amphotericin B liposomal and developed hyperphosphataemia, which led to drug...

  • Experimental Pulmonary Aspergillosis Due to Aspergillus terreus: Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B. Walsh, Thomas J.; Petraitis, Vidmantas; Petraitiene, Ruta; Field-Ridley, Aida; Sutton, Deanna; Ghannoum, Mahmoud; Sein, Tin; Schaufele, robert; Peter, Joanne; Bacher, John; Casler, Heather; Armstrong, derek; Espinel-Ingroff, Anna; Rinaldi, Michael G.; Lyman, Caronh A. // Journal of Infectious Diseases;7/15/2003, Vol. 188 Issue 2, p305 

    Aspergillus terreus is an uncommon but emerging fungal pathogen, which causes lethal infections that are often refractory to amphotericin B (AmB). In comparison to Aspergillus fumigatus, A. terreus was resistant to the in vitro fungicidal effects of safely achievable concentrations of AmB. These...

  • Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis. Person, A. K.; Chudgar, S. M.; Norton, B. L. // Journal of Invasive Fungal Infections;2010, Vol. 4 Issue 4, p148 

    The case of a 72-year-old female diagnosed with pulmonary infection secondary to Aspergillus niger that did not respond to voriconazole therapy is presented in this article.

  • Treatment of murine systemic aspergillosis with polyene-intralipid admixtures. Sionov, Edward; Segal, Esther // Medical Mycology;Feb2004, Vol. 42 Issue 1, p73 

    The objective of this research was the evaluation of the activity of admixtures of amphotericin B (AMB) - intralipid (AMB-IL) and nystatin (Ny) - intralipid (Ny-IL) against experimental systemic aspergillosis in immunocompromised mice. ICR mice were transiently immunosuppressed by...

  • Aspergillosis in the CLEAR outcomes trial: working toward a real-world clinical perspective. Kleinberg, M. // Medical Mycology;Feb2005 Supplement 1, Vol. 43, p289 

    Aspergillosis is a potentially lethal infection of immunocompromised patients. Until 10 years ago, antifungal therapy was largely limited to amphotericin B deoxycholate. Perceived poor response rates and inherent toxicities with amphotericin B deoxycholate were a major stimulus for the...

  • Primary Cutaneous Aspergillosis. Nakashirna, Keiko; Yamada, Nanako; Yoshida, Yuichi; Yamamoto, Osamu // Acta Dermato-Venereologica;2010, Vol. 90 Issue 5, p519 

    The article presents a case study of a 66-year-old Japanese woman with an asymptomatic nodule on the tip of her right thumb. Histopathology revealed a massive epidermal necrosis and dermal necrobiosis. She was diagnosed with primary cutaneous aspergillosis caused by Aspergillus (A.) flavus. The...

  • Voriconazole dominates liposomal amphotericin B in aspergillosis.  // PharmacoEconomics & Outcomes News;12/3/2005, Issue 492, p8 

    The article presents information on a study which found that voriconazole is cost effective than liposomal amphotericin B in patients with probable or proven invasive aspergillosis in Great Britain. The results of the study was presented at the 8th Annual European Congress of the International...

  • Emericella quadrilineata as Cause of Invasive Aspergillosis. Verweij, Paul E.; Varga, J├ínos; Houbraken, Jos; Rijs, Antonius J.M.M.; VerduynLunel, Frans M.; Blijlevens, Nicole M.A.; Shea, Yvonne R.; Holland, Steven M.; Warris, Adilia; Melchers, Willem J. G.; Samson, Robert A. // Emerging Infectious Diseases;Apr2008, Vol. 14 Issue 4, p566 

    We noted a cluster of 4 cases of infection or colonization by Emericella spp., identified by sequence-based analysis as E. quadrilineata. Sequence-based analysis of an international collection of 33 Emericella isolates identified 12 as E. nidulans, all 12 of which had previously been identified...

  • Two Cases of Cerebral Aspergillosis Successfully Treated with Voriconazole. de Lastours, V.; Lefort, A.; Zappa, M.; Dufour, V.; Belmatoug, N.; Fantin, B. // European Journal of Clinical Microbiology & Infectious Diseases;May2003, Vol. 22 Issue 5, p297 

    Described here are two cases of cerebral aspergillosis successfully treated with voriconazole after the failure of first-line treatment with amphotericin B deoxycholate. In both cases, clinical and radiological cure was achieved within 6 weeks. Voriconazole should be considered as first-line...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics